Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

June 16, 2015

tony w

The Journal of Clinical Pharmacology